Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells
暂无分享,去创建一个
S. Lancel | C. Bailly | C. Fournier | J. Beauvillain | A. Loyens | J. Kluza | P. Marchetti | Miguel-Angel Gallego
[1] S. Mordon,et al. Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production* , 2004, Critical care medicine.
[2] K. Gunter,et al. Bcl-2 prevents abnormal mitochondrial proliferation during etoposide-induced apoptosis. , 2003, Experimental cell research.
[3] R. Danesi,et al. Cardiac toxicity of antineoplastic anthracyclines. , 2003, Current medicinal chemistry. Anti-cancer agents.
[4] L. Corcos,et al. Mitochondria as a Target for Inducing Death of Malignant Hematopoietic Cells , 2003, Leukemia & lymphoma.
[5] C. Chi,et al. Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. , 2002, Journal of biomedical science.
[6] B. van de Water,et al. Differential Regulation of Doxorubicin-induced Mitochondrial Dysfunction and Apoptosis by Bcl-2 in Mammary Adenocarcinoma (MTLn3) Cells* , 2002, The Journal of Biological Chemistry.
[7] S. Kaufmann,et al. Apoptosis and the response to anticancer therapy , 2001, Current opinion in oncology.
[8] E. Fleck,et al. The Apoptotic Regulatory Protein ARC (Apoptosis Repressor with Caspase Recruitment Domain) Prevents Oxidant Stress-mediated Cell Death by Preserving Mitochondrial Function* , 2001, The Journal of Biological Chemistry.
[9] K. Roemer,et al. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents , 2001, Oncogene.
[10] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[11] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[12] P. Paty,et al. Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line , 1997, The Journal of cell biology.
[13] K. Wallace,et al. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin. , 1996, Journal of molecular and cellular cardiology.
[14] M. Castedo,et al. Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.
[15] J. Hickman,et al. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. , 1995, Experimental cell research.
[16] S H Kaufmann,et al. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.
[17] R. O. Poyton,et al. Crosstalk between nuclear and mitochondrial genomes. , 1996, Annual review of biochemistry.
[18] C. Riccardi,et al. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. , 1993, European journal of cancer.